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REST mediates resolution of  
HIF-dependent gene expression  
in prolonged hypoxia
Miguel A. S. Cavadas1,2,3, Marion Mesnieres2, Bianca Crifo2, Mario C. Manresa2, 
Andrew C. Selfridge2, Carsten C. Scholz1,2,4, Eoin P. Cummins2, Alex Cheong1,2,5,* & 
Cormac T. Taylor1,2,*
The hypoxia-inducible factor (HIF) is a key regulator of the cellular response to hypoxia which promotes 
oxygen delivery and metabolic adaptation to oxygen deprivation. However, the degree and duration 
of HIF-1α expression in hypoxia must be carefully balanced within cells in order to avoid unwanted side 
effects associated with excessive activity. The expression of HIF-1α mRNA is suppressed in prolonged 
hypoxia, suggesting that the control of HIF1A gene transcription is tightly regulated by negative 
feedback mechanisms. Little is known about the resolution of the HIF-1α protein response and the 
suppression of HIF-1α mRNA in prolonged hypoxia. Here, we demonstrate that the Repressor Element 
1-Silencing Transcription factor (REST) binds to the HIF-1α promoter in a hypoxia-dependent manner. 
Knockdown of REST using RNAi increases the expression of HIF-1α mRNA, protein and transcriptional 
activity. Furthermore REST knockdown increases glucose consumption and lactate production in a 
HIF-1α- (but not HIF-2α-) dependent manner. Finally, REST promotes the resolution of HIF-1α protein 
expression in prolonged hypoxia. In conclusion, we hypothesize that REST represses transcription of 
HIF-1α in prolonged hypoxia, thus contributing to the resolution of the HIF-1α response.
Hypoxia is a key microenvironmental feature of a range of physiological and pathophysiological conditions includ-
ing embryonic development, exercise, cancer, ischemia and inflammation1. Adaptive transcriptional pathways 
have evolved to help an organism deal with the metabolic threat posed by hypoxia. The best-described transcrip-
tional adaptive response in cells is mediated by the hypoxia inducible factor (HIF) signalling pathway, which 
up-regulates genes which restore oxygen and energy homeostasis2–4. In normoxia, HIFα is hydroxylated by the 
prolyl-hydroxylase domain (PHD) family of dioxygenases targeting it for proteosomal degradation5. This process 
is reversed in hypoxia and HIFα is stabilized, dimerizes with HIFβ and binds to hypoxia response elements (HRE) 
in the regulatory regions of target genes6. HIF drives an adaptive response to hypoxia by promoting the expres-
sion of genes including those that regulate erythropoiesis, angiogenesis and glycolysis6. However in cancer, HIF 
signalling can be maladaptive and contribute to tumour survival1. Because of the potentially deleterious effects of 
over-activation of the HIF pathway, a resolution mechanism is required to resolve its activity in prolonged hypoxia. 
In the absence of such a resolving mechanism, deleterious consequences such as pathologic angiogenesis and 
excessive haematocrit due to chronic HIF stabilization may occur7–9.
While several regulators of HIF expression exist, only a few have been shown to be involved in the resolution of 
the HIF response to hypoxia. PHD2 and PHD3 are, for example, part of an auto-regulatory mechanism, whereby 
HIF-1α which is stabilized in hypoxia, transcriptionally induces the expression of EGLN1 and EGLN3 genes 
coding for PHD2 and PHD3 proteins respectively10–12. The increased expression of the PHD enzymes in turn 
promotes HIFα hydroxylation, and reduction of its expression in prolonged hypoxia10. Less is known about the 
control of HIF1A mRNA stability11. Interestingly, while HIF-1α protein is transiently up-regulated in hypoxia, 
the mRNA is frequently found to be repressed12–15. This transcript attenuation can be conveyed through mRNA 
destabilization by the protein tristetraprolin in endothelial cells14 and by miR155 in intestinal epithelial cells12. 
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The HIF-1α antisense transcript (aHIF) which is widely expressed in both adult and foetal tissue16 has also been 
shown to down-regulate HIF-1α mRNA in lymphocytes, non-papillary renal cell carcinoma and lung epithelial 
cells13,15. All these different mechanisms converging on the reduction of mRNA expression in hypoxia indicate 
that this may be an important component of the cellular adaptation to hypoxia, potentially preventing an over 
activated HIF response that could be detrimental to cells and tissues12. Further supporting this protective role of 
reduced HIF1A mRNA expression in hypoxia, high levels of HIF1A mRNA have been observed in hepatocellular 
carcinoma, gastric cancer and prostate cancer and are often associated with poor prognosis17–20. Of note, the sup-
pression of HIF1A mRNA expression in prolonged hypoxia may be dependent on cell type as some reports have 
reported induction of HIF1A mRNA in hypoxia21–26.
Both HIF-1α protein and HIF1A mRNA are overexpressed in cancer, correlating to poor prognosis. While 
increased HIF-1α protein levels could be caused by increased oncogenic activity from PI3K/Akt/mTOR and MYC, 
decreased VHL expression and tumour hypoxia27–30, there is no clearly identified transcriptional mechanism for 
the over-expression of HIF1A mRNA in cancer. NFκ B24,31 and NFAT32 have been shown to increase HIF1A mRNA 
expression, however their relative roles in regulating HIF1A transcription in the cancer context remain to be fully 
elucidated. The V-SRC oncogene has been shown to increase HIF-1α mRNA, however the mechanism remains 
poorly understood27. Therefore, the regulation of HIF-1α expression is subject to both conserved post-translational 
mechanisms and context dependent transcriptional and post-transcriptional events which are necessary for phys-
iological oxygen homeostasis but can also be inappropriately activated in cancer to promote tumour progression.
The Repressor Element 1-Silencing Transcription Factor (REST) is a C2H2- or Krüppel-type zinc finger, one of 
the largest classes of transcription factors in humans33. It binds to the 21 base pair Repressor Element 1 (RE1) on 
the promoter of target genes and inhibits transcription by regulating chromatin structure or by inhibiting the basal 
transcription machinery34. Proteosomal REST degradation is induced during neuronal differentiation, resulting 
in the promotion of expression of genes which confer a unique neuronal phenotype34,35. REST also regulates gene 
expression in non-neuronal cells36–40.
While the inhibition of PHD enzymes is fundamental for HIF-1α protein stabilization in hypoxia, much less 
is known about the resolution of the HIF-1α protein response and the suppression of HIF-1 α mRNA in hypoxia. 
Analysis of the HIF1A promoter revealed the presence of several components of the REST co-repressor complex 
(REST, mSin3A, CoREST and HADAC2). Due to the previous implication of REST in ischemia we decided to 
investigate the contribution of REST to HIF-1α regulation in hypoxia.
Here we show that REST regulates cell metabolism by counter-regulating HIF-1α dependent transcription, 
including the regulation of glycolytic genes. This work also sheds light on our understanding of the crosstalk 
between transcriptional repressors and activators in the cellular response to hypoxia, a key event in a range of 
physiologic and pathophysiologic processes.
Results
HIF-1α protein is transiently stabilized in hypoxia while its mRNA is suppressed. The HIF-1α 
response in prolonged hypoxia involves a rapid protein accumulation phase (Fig. 1A–F), followed by a protein 
resolution phase, where HIF-1α levels decay back to close to normoxic levels (Fig. 1A–F). In the HEK293 cell line, 
HIF1A mRNA expression decreased by only 21% to 32% after 8 hours of exposure to hypoxia (Figs 1G and 3E). 
In other cell lines including the intestinal epithelial cancer cell line CaCo-2 and in HeLa cells, HIF1A mRNA has 
been reported to decreased by ~ 50% after 6 to 8 hours of hypoxic exposure (1% oxygen)12,41. Here, we observed 
that in normal breast and breast cancer derived cell lines, HIF1A mRNA expression can decrease by 50 to 80% 
after 8 hours of hypoxic exposure (Fig. 1G). Thus, suppression of HIF1A mRNA is common in response to hypoxia.
NFκ B has been shown to be responsible for the transient and early HIF1A mRNA induction in response to 
hypoxia, 1% oxygen, in human pulmonary arterial smooth muscle cells24. Therefore we decided to test if in HEK293 
cells NFκ B was recruited to the HIF1A κ B element previously shown to bind p50 and p65 in response to hypoxia 
and activate HIF1A transcription24. Using chromatin immunoprecipitation assays (ChIP), with a rabbit p65 anti-
body or rabbit IgG negative control antibody from pre-immune sera, chromatin pull-downs were performed, 
and qRT-PCR was used to quantify the chromatin containing the HIF1A κ B element. This revealed that p65 was 
transiently recruited to the κ B site on the HIF1A promoter in response to hypoxia, being significantly up-regulated 
in comparison to normoxia and IgG at 8 hours (Fig. 1H). Despite the recruitment of p65 to the κ B site on the 
HIF1A promoter, HIF1A mRNA is still significantly decreased in hypoxia (Figs 1G and 3E), this indicates that 
counter-regulatory mechanisms must be acting either at the level of regulating mRNA transcription or stability. 
We next investigated the possibility that a transcriptional repressor was counter-regulating NFκ B-dependent 
activation of HIF1A gene transcription (see below).
REST negatively regulates HIF-1α. The protein tristetraprolin14, the microRNA miR155, and the lncRNA 
aHIF13,16 have all been shown to regulate HIF1A mRNA stability, but no example is known of a transcriptional 
mechanism directly acting on the HIF1A promoter. Therefore, we decided to use the ENCODE consortium 
ChIP-Seq datasets to determine which transcriptional repressors are bound to the human HIF1A promoter region, 
4000 bp upstream and 2000 bp downstream of the ATG (Fig. 2A,B). This revealed the presence of multiple tran-
scription factors (Fig. S1), among which were members of the REST co-repressor complex, namely REST, mSin3A, 
RCOR1 (CoREST), and HDAC2 (Fig. 2B)34. Due to the previous implication of REST in the response to ischaemia, 
we decided to test if REST was involved in the repression of HIF1A gene transcription. Using the JASPAR database, 
we looked for putative REST binding sites (RE1) on the HIF1A promoter region covered by the ChIP-Seq hits of 
the REST co-repressor complex family of nuclear factors (Fig. 2C). And identified an RE1 which was evolutionarily 
conserved within primates, but diverged in other mammals (62 to 81% conserved base pairs in the RE1 site) and 
was not present in more distant animal species having REST orthologous proteins (Fig. 2D). REST binding to this 
RE1 site was validated in human HEK293 cells using ChIP assays coupled to qRT-PCR using primers that amplified 
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Figure 1. HIF-1α protein is transiently stabilized in hypoxia while its mRNA its suppressed. (A) HEK293, 
(C) MCF10A, (D) MCF7 and (E) MDA-mb-231 cells where exposed to the indicated time point to hypoxia  
(1% oxygen), protein lysates where prepared and blotted with the indicated antibodies. (B–F), densitometry of 
(A) and (C–E), respectively. (G) Cells where exposed to 8 hours of hypoxia (1% oxygen) or normoxia  
(21% oxygen), the mRNA was collected and used for qRT-PCR analysis of HIF1A mRNA expression. Results 
are shown as fold change to normoxia. (H) ChIP assays coupled to qRT-PCR where performed on HEK293 cells 
exposed to hypoxia for the indicated time points using p65 and IgG control antibodies, primers covering the 
NFκ B site on the HIF-1α gene where used (see sequence highlighted in blue in Fig. 3A). N = 3-4 independent 
experiments. Data are represented as mean ± SEM. In (G), *p < 0.05, ***p < 0.001, significant fold change over 
21% O2. In (A), *p < 0.05, significant increase over normoxic p65 ChIP and IgG ChIP.
www.nature.com/scientificreports/
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Figure 2. Bioinformatics work flow used to identify the REST binding site (RE1) on the HIF1A promoter. 
(A) The HIF1A gene with mammalian conservation is depicted in relation to its position on chromosome 
14 q23.2 (modified from the UCSC Genome Browser). The human HIF1A promoter region -4000 bp 
upstream to + 2000 bp downstream of the translation start site (ATG) was used to screen for the presence of 
REST-repressor complex components on the ENCODE ChIP-seq datasets. This is a highly conserved region 
surrounding EXON1. The full list of transcription factors found to be associated on this region of the HIF1A 
gene is described in Fig. S1. (B) Close up view on the ChIP-seq hits found for the REST co-repressor complex 
components: REST, mSin3A, CoREST (RCOR1) and HDAC2 on the HIF1A gene promoter. Conservation is 
depicted by vertical blue bars, bellow the ChIP-seq hits (horizontal grey-scale bars). (C) The genomic DNA 
where REST co-repressor complex ChIP-seq hits was found, was screened using the JASPAR database for the 
presence of RE1 elements, this revealed a putative RE1 in the -491 bp to 0 bp promoter region (highlighted 
in red), in close proximity to the previously reported NFκ B site on the HIF1A gene (highlighted in blue). 
Red arrow, indicated the highest scoring putative RE1 (Rest binding site) found by JASPAR analysis. (D) 
Conservation of the RE1 site in the HIF1A promoter is depicted. See Materials and Methods for more details on 
the Bioinformatics analysis.
www.nature.com/scientificreports/
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a 62  bp amplicon containing the RE1 site (Fig. 3A). REST and its co-repressor proteins CoREST and mSin3A were 
found to be recruited to the HIF-1α gene with similar dynamics (Fig. 3B). Thus, we identified a functional RE1 
site in the HIF1A promoter that binds REST and its co-repressors CoREST and mSin3A.
To test if REST had a functional effect on HIF1A expression, in addition to its binding to the HIF1A promoter, 
REST knockdown using RNAi was used in HEK293 and MCF7 cells. This led to a significant increase in HIF-1α 
protein (Fig. 3C–F) and mRNA (Fig. 3G), suggesting that REST is a negative transcriptional regulator of HIF-1α 
expression at least in hypoxia. In HEK293 cells we did not observe up-regulation of HIF-2α in response to hypoxia42 
and MCF7 cells did not show any change in HIF-2α upon REST knockdown (Fig. 3E,F). We also observed that 
HEK293 cells overexpressing REST had reduced expression of HIF-1α protein (Figure S2).
Together these findings provide evidence that REST negatively regulates HIF-1α through promoting the the 
assembly of a REST repressor complex on the HIF1A promoter cis-regulatory RE1 element. The data provide insight 
into the mechanisms underpinning attenuation of HIF1A mRNA expression in prolonged hypoxia.
REST is involved in the resolution of the HIF-1α response. Data presented thus far demonstrates 
that REST negatively regulates HIF-1α . We next investigated whether REST is involved in the resolution of the 
HIF-1α -dependent functional response. Typically, in vitro, HIF-1α protein accumulates quickly in response to 
hypoxia, but the response is decreased over prolonged exposure (Fig. 4A, B-black bars). Upon REST knockdown, 
HIF-1α protein rapidly accumulated in hypoxia, but did not decrease under prolonged hypoxia. Instead the HIF-1α 
response plateaued (Fig. 4A, B-red bars), indicating that REST may be involved in the resolution of the HIF-1α 
response. These findings were further confirmed by the increased HIF-1α -reporter activity under prolonged 
hypoxia when REST is knocked down (Fig. 4C), and decreased HIF-1α reporter activity when REST is overex-
pressed (Fig. 4D). Endogenous HIF-1α transcriptional activity under REST knock-down was also increased, as 
accessed by increased mRNA expression of the HIF-1α target genes PHD2 and PHD3 (Fig. 4E,F).
Our data shows that REST plays a role in the suppression of HIF-1α protein expression and transcriptional 
activity in prolonged hypoxia. Thus there is clear indication for the involvement of REST in the resolution of the 
HIF-1α response.
Figure 3. REST negatively regulates Hif-1α. (A) Schematic representation of the HIF1A genomic locus, 
grey rectangles indicate approximate Exon position, the white rectangle with diagonal black lines indicates 
the genomic sequence -491 bp/ATG of the human HIF1A gene. Highlighting is the REST binding site (RE1) 
in red, and the previously reported NFκ B binding site in blue, on the -491 bp/ATG genomic sequence. Blue 
arrows indicate the primers used to detect REST, COREST, mSin3A and IgG binding to the RE1 site in the ChIP 
assays. (B) ChIP assays on the RE1 site in the HIF1A gene promoter using the indicated antibodies in HEK293 
cells exposed to the indicated time points to hypoxia (1% oxygen). Precipitated chromatin was quantified by 
qRT-PCR. (C–G) Cells were exposed to hypoxia (1% O2) for the indicated time points. REST knockdown was 
performed using REST specific (REST-RNAi) or control RNAi (C–G). Whole cell extracts from HEK293 (C,D) 
and MCF7 (E,F) were collected and analysed for the expression of the indicated protein by immunoblotting 
(C,E) and densitometry analysis (D,F). HEK293 mRNA was collected and analysed for HIF mRNA expression 
by qRT-PCR (G). F.C. = fold change to 21% O2 for (G) and control RNAi, 8 hours hypoxia for (C–F). Data are 
represented as mean ± SEM, N = 3–5 throughout. *p < 0.05, significant change over control RNAi.
www.nature.com/scientificreports/
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REST regulates glycolytic metabolism in hypoxia. Having observed that HIF-1α activity is increased 
under prolonged hypoxia when REST levels are decreased by RNAi, we next investigated whether this is reflected 
by altered functional responses to hypoxia. The mRNA expression levels of four well described HIF-1α target 
genes encoding proteins known to be involved in glucose metabolism (HK2, LDHA, SLC2A1 and PFKFB3) were 
measured. In hypoxia, the expression of these genes was increased upon loss of REST (Fig. 5A–D). These results 
suggest that REST loss could affect glucose metabolism by increasing glucose consumption. We measured glu-
cose consumption and lactate production in HEK293 cells and observed that, in hypoxia (1% oxygen), knock-
down of REST resulted in enhanced glucose consumption and lactate production (Fig. 5E,F). Thus we show 
that REST supresses hypoxia-induced glucose consumption and lactate production via repression of HIF-1α . In 
conclusion, we identify REST as a repressor of gene expression in hypoxia which acts through the repression of 
HIF-1α -dependent transcription.
Discussion
The regulation of HIF-1α expression is well documented at the protein level, but much less is known about the 
control of its mRNA stability11. Interestingly, while HIF-1α protein is transiently up-regulated, the mRNA is 
actually repressed12–15. This transcript attenuation can be conveyed through mRNA destabilization by the protein 
tristetraprolin in endothelial cells14 and by miR-155 in intestinal epithelial cells12. The HIF-1α antisense transcript 
(aHIF), which is widely expressed in both adult and foetal tissue16, has also been shown to down-regulate HIF-1α 
mRNA in lymphocytes, non-papillary renal cell carcinoma and lung epithelial cells13,15. All these different mech-
anisms converging to the reduction of mRNA expression in hypoxia indicate that this is an important adaptation 
to hypoxia, potentially to prevent an over activated HIF response that could be detrimental to cells and tissues12. 
Further supporting this protective role of reduced HIF-1α mRNA expression in prolonged hypoxia, high levels 
of HIF-1α mRNA have been observed in hepatocellular carcinoma, gastric cancer and prostate cancer and often 
associated to poor prognosis17–20.
Here, we demonstrate the existence of a transcriptional repressor mechanism acting on the HIF1A promoter 
response to prolonged hypoxia. This data together with the recruitment of p65 to the HIF1A promoter (Fig. 1H) 
indicates that HIF1A transcription is under the tight control of both a transcriptional activator and a repressor in 
response to hypoxia, and de-regulation of this balance might contribute to changes in HIF1A mRNA expression. 
This can be expected to occur in situations where p65 is activated including inflammatory settings43 and when 
REST is down-regulated including cancer35. Of interest, other examples exist of genes counter-regulated by NFκ B 
and REST44. The neurotransmitter gene TAC1 is repressed in mesenchymal stem cells (MSC) and their normal 
lineage differentiated progeny Bone Marrow (BM) stromal cells, by REST and NFκ B, but not in retinoic acid dif-
ferentiated cells used to induce neuronal trans-differentiation of MSC44. Of notice, although NFκ B activation is 
Figure 4. REST is involved in the resolution of the Hif-1α response and in the repression of HIF-1α-
dependent transcription. (A–F) HEK293 cells were exposed to 21% and 1% oxygen for the indicated time 
points. REST knockdown was performed using REST-RNAi while REST overexpression was performed with 
msREST-FLAG construct. (A) Whole cell extracts were prepared and immunoblotted as indicated to  
assess the changes in HIF-1α protein expression under prolonged hypoxia and upon REST knockdown.  
(B) Densitometry of (A). (C,D) HRE-luciferase assays were performed to assess changes in HIF activity upon 
REST knock-down (C) or over-expression (D), using the pHRE-MP-GLuc construct. EV = Empty vector 
control. FC = Fold change to EV control at 24 hr hypoxia. (E,F) mRNA was collected and analysed for the 
expression of the indicated HIF-1α target genes PHD2 and 3, to assess the changes in endogenous HIF-1α 
transcriptional activity. FC = Fold change to Ctrl_RNAi in hypoxia. Data are represented as mean ± SEM, 
N = 3–5 throughout. *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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observed after 8 hours of hypoxia (Fig. 1H), no induction of HIF1A mRNA is observed in REST knockdown cells 
(Fig. 3G), indicating REST-independent mechanisms involved in the repression of NFκ B -induced transcription 
(e.g. tristetraprolin, miR-155 and aHIF).
REST knockdown had no effect on HIF-2α protein expression (Fig. 3D). Of notice, miR-155 and aHIF, known 
regulators of HIF1A mRNA also exhibit specificity towards HIF-1α , without an effect on EPAS1 (gene coding for 
HIF-2α ) mRNA expression12,13. EPAS1 mRNA is generally not repressed by hypoxia like HIF1A mRNA12,13, it is 
therefore not entirely surprising that the mechanisms that lead to HIF1A mRNA repression in hypoxia do not affect 
EPAS1 mRNA expression. In conclusion, REST regulates HIF-1α , but not HIF-2α expression at least in MCF7 cells.
The tumour suppressor role of REST in non-neuronal cells has been linked to proliferative pathways35,38. 
However, the exact mechanisms whereby REST induces these changes remain unknown35. In this work we have 
shown that REST reduces HIF-1α expression and glycolysis in hypoxia, two promising targets for cancer therapy45. 
Thus our molecular biology findings have the potential to be of clinical importance in cancer, and expands the 
current knowledge about the mechanisms whereby REST might exert its tumour suppressor role. Our data sug-
gest that in the absence of REST, as it occurs in REST-less tumours, there is no repression of HIF1A transcription, 
therefore positive regulators like NFκ B are able to freely drive HIF1A transcription, leading to increased HIF-1α 
protein expression in hypoxic tumour microenvironments. Indeed, we observe that the tumour cell line HepG2, 
which displays HIF1A mRNA induction in hypoxia, has lower REST level than HEK293 (Figure S3). HIF activates 
Figure 5. REST loss of function promotes expression of HIF-1α target genes involved in glycolysis, leading 
to increased glucose consumption and lactate production. (A–F) HEK293 cells were exposed to 21% and 
1% oxygen for the indicated time points. REST knockdown was performed using REST-RNAi. The mRNA 
was collected and analysed by qPCR for the expression of the HIF-1α target genes (A) HK2, (B) LDHA, (C) 
SLC2A1 and (D) PFKFB3. (E) glucose consumption and (F) lactate production assays where performed. Data 
are represented as mean ± SEM, N = 3–6 throughout. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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several processes that confer an advantage for the development of cancer46. Among these processes is glycolysis, 
which facilitates energetic adaptation to the hypoxic environment47.
In addition, glycolysis is also known to be correlated to increased tumour aggressiveness, as it facilitates aci-
dosis, eliminating normal cells surrounding the acidic environment or inducing mutations that will transform 
these cells, and is able to stimulate in vitro invasion and in vivo metastases, potentially by inducing extracellular 
matrix degradation46,47.
REST is a tumour suppressor in non-neuronal cancers of the breast, colon and lung, therefore increasing the 
range of pathophysiological settings were our findings might be of importance in the regulation of the HIF-1α 
response and glycolysis45. HIF-1α regulation by oncogenic pathways has been shown to operate mostly by 
increasing protein expression or decreasing its degradation45,48. Over-activation of the PI3K/Akt/mTOR path-
ways leads to increased HIF1A mRNA translation and inactivation of VHL can lead to decreased HIF-1α protein 
degradation27–30,45,49.
HIF1A mRNA is also overexpressed in cancer, correlating to cancer aggressiveness11,17,50. However, there is 
no clear known mechanism explaining this overexpression45. The transcription factors NFκ B24,31 and NFAT32 
are described to transcriptionally activate HIF1A in response to inflammatory stimuli and in activated mast cells, 
respectively. In many situations the cancer microenvironment can be inflamed, and inflammation can drive can-
cer development, but the roles of NFκ B and NFAT in regulating HIF1A in this context remain to be fully eluci-
dated11. The V-SRC oncogene has been shown to increase HIF1A mRNA, however the mechanism remains poorly 
understood27.
In this work, we have observed that loss of REST by genetic manipulation leads to increased HIF-1α expression, 
while increased REST levels lead to reduced HIF-1α expression. Thus REST is a tumour suppressor gene that tran-
scriptionally represses HIF1A. We hypothesize that loss of the tumour suppressor REST51 being the only known 
transcriptional repressor of HIF1A transcription, would allow the positive transcriptional regulators of HIF1A to 
drive its transcription, explaining its over-expression in several cancers. Taken together these observations suggest 
that our findings may be of clinical importance, as they provide insight into the crosstalk between hypoxia, HIF-1α , 
glycolysis and REST, all of which play important roles in solid tumours35,52.
We have shown that in hypoxia REST is recruited to the HIF1A promoter, together with the co-repressors 
CoREST and mSin3A. These co-repressor complexes have associated enzymes with chromatin modifying activity 
including histone deacetylases, histone methytransferases and demethylases, and methyl-CpG-binding protein 2 
(MeCP2)34, thus suggesting that REST serves as a platform for the hypoxia induced epigenetic silencing of HIF1A 
expression in hypoxia. This would counteract the recruitment of NFκ B to the HIF1A promoter, which has been 
associated to increased transcription in hypoxia24. Together these two regulators REST and NFκ B may act to fine 
tune HIF1A expression according to environmental clues, and de-regulation of the expression of one of these tran-
scription factors is expected to affect HIF1A expression, as it can happen in inflammatory diseases43 and REST-less 
tumours35. Of interest MeCP2, a protein often associated with the long term silencing by the REST co-repressor 
complex, and usually found in the vicinity of the RE1 element34,53, has been found in the HIF1A promoter region, 
upstream of the ATG, in close proximity to the RE1 we identified on HIF1A54.
In clear cell renal cell carcinoma (CCRCC) VHL-defective RCC4 and RCC10 cells, binding of HIF-1α /2α to 
the reverse HRE (rHRE) on the HIF1A promoter, leads to H3K9 methylation, H3K4 de-methylation and HIF1A 
repression55. Binding of HIF-α subunits to rHREs has been described as a mechanism to repress transcription in 
hypoxia56,57. Interestingly, these methylation changes are classical marks of REST-mediated epigenetic silencing34. 
The authors of the previous study speculate on the recruitment, through as yet unknown mechanisms, of com-
plexes carrying histone modifying activities to mediate these epigenetic changes55. Of note this rHRE is located 
up-stream of the ATG, in close proximity to the RE1 we identified. In summary, the HIF1A promoter contains 
epigenetic marks associated with REST (e.g. methylated H3K9) or chromatin modifying proteins associated with 
the REST co-repressor complex (e.g. MeCP2), this together with our findings of the recruitment of REST and its 
co-repressor complexes mSin3A and CoREST to the HIF1A promoter suggests a role for REST as an epigenetic 
regulator of HIF1A.
In conclusion, our findings have identified REST as a key repressor of HIF1A gene transcription and it’s down-
stream glycolytic genes, playing a key role in cellular adaptation to hypoxia.
Materials and Methods
Cell culture. Human embryonic kidney cells (HEK-293) and human tumorigenic mammary epithelial cells 
(MCF7 and MDA-MB-231) were cultured in Dulbecco’s modified eagle medium (DMEM, high glucose 4.5 g/L 
without pyruvate) supplemented with 10% foetal calf serum (FCS) and 100 U/mL penicillin-streptomycin (PS). 
Human non-tumorigenic mammary epithelial cells (MCF10A) were grown in DMEM/F12 with 5% horse serum, 
100 U/mL PS, 2 mM L-Glutamine, 10 μ g/mL insulin, 20 ng/mL Epidermal Growth Factor (EGF), 0.5 μ g/mL hydro-
cortisone and 100 ng/ml cholera toxin. Human liver carcinoma HepG2 cells were maintained in minimum essen-
tial medium containing 10% FCS, 2 mM L-glutamine, nonessential amino acids, and 100 U/ml PS. All cells were 
obtained from the American Type Culture Collection (ATCC). All reagents for cell culture were from Gibco (Life 
Technologies, Calrsbad, CA, USA), unless otherwise stated. Cells were exposed to hypoxia using pre-equilibrated 
media and maintained in standard normobaric hypoxic conditions (1% O2, 5% CO2 and 94% N2) in a hypoxia 
chamber (Coy Laboratories, Grass Lake, Michigan, USA). Normoxic controls were maintained at atmospheric O2 
levels (21% O2, 5% CO2 and 74% N2) in a tissue culture incubator.
Gaussia luciferase assay, transient and stable transfections. Gaussia luciferase assays were performed 
as previously described58. Briefly, at the selected time points, 10 μ L of media was collected from the supernatant and 
stored at –20 °C. Gaussia luciferase activity was measured using the Biolux Gaussia luciferase Flex Assay kit (NEB) 
in a plate reader (Synergy HT, Biotek) and normalized to the luciferase activity of the secreted cypridina luciferase 
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under the control of a constitutive CMV promoter (pCMV-CLuc) or protein concentration. The pHRE-MP-GLuc 
HIF responsive construct has been previously described58. The pCMV-CLuc construct was from NEB (N0321S, 
pCMV-CLuc 2). Plasmid sequencing was performed by MWG Eurofins, Germany.
Cell transfection with siRNA and transient REST overexpression construct. Transient transfection 
with siControl (sc-37007, SCB) and siREST (s11932, Life Technologies) were performed as previously described42. 
Transfections with siRNA to be used in luciferase assays were performed in 24 well plates, as described above. All 
other experiments were performed on 6 well plates unless otherwise stated. In a typical experiment 200 K cells 
were seeded on 6 well plates and allowed to grow until approximately 60% confluent, at this time cells were trans-
fected with 2 μ L of Lipo, 100 μ L Optimem and a pre-optimized amount of overexpressing construct (100 ng) or 
siRNA (100 pmol). Cells were media changed to 2 mL of conditioned media on the day after transfection. In order 
to keep the same transfection times with the siRNA, in experiments were hypoxic exposures were longer than 
16 hrs, cells were conditioned to hypoxia on different days and lysed on the same day. For RNA extraction exper-
iments, siRNA was incubated for 48 hrs. For the preparation of whole cell protein extracts, siRNA was incubated 
for 72 hrs. For the experiments where the role of REST in the resolution of the HIF-1α response was investigated 
(Fig. 4A,B), HEK293 cells were stably transfected with a plasmid coding for a short-hairpin RNA (shRNA) targeting 
the coding sequence of REST mRNA (sc-38129-SH, Santa Cruz) or a control shRNA plasmid (sc-108060, Santa 
Cruz), and selected with puromycin, according to the manufacturer instructions. For experiments where REST 
was overexpressed using msREST-FLAG, 80 K cells were seeded on 12 well plates, and cells were transfected with 
100 ng msREST-FLAG, 100 ng HREG and 50 ng pCMV-CLuc with 100 μ L Optimem and 1 μ L Lipo. The media 
was changed to fresh media on the day after transfection.
qRT-PCR. cDNA was synthesized from 1 μ g of RNA using MMLV (Promega), and amplified using the Prism 
7900HT sequence detection system (Applied Biosystems, Foster City, CA) under default conditions. The mRNA 
relative expression was calculated by the ∆∆Ct method by normalizing the Ct of the samples to that of 18S rRNA 
(TaqMan Universal PCR Master Mix with the primer 18S rRNA-Euka, 4310893E, Life Technologies), followed by 
normalization to the control condition. The following qRT-PCR primers were used:
HIF1A, F: ACAAGTCACCACAGGACAG, R: CGACTTGATTTTCTCCCT
HK2, F: TCCCCTGCCACCAGACTA, R: CCAAGGGATTCAAGTCCA
LDHA, F: GAGGTTCACAAGCAGGTGGT, R: AGTGTTCCTTGCATTTTGGG
SLC2A1, F: GATTGGCTCCTTCTCTGTGG, R: AAACTGGGCAAGTCCTTTGA
PFKFB3, F: ACAGCTTTGAGGAGCATGTG, R: AAACATGAAAGGCTCCCG
PHD2, F: GCACGACACCGGGAAGTT, R: ACTGTAACGGGAAGCTGG
PHD3, F: ATCGACAGGCTGGTCCTCTA, R: ACAAGAATTGGGATGCCAAG
Western blot. All reagents were from Sigma unless otherwise stated. Standard protocols were used as pre-
viously described42,59. Mouse β -actin, 1:10000, Sigma, A5441; Mouse HIF-1α ,1:1000, BD Pharmingen, 610958; 
Rabbit HIF-2α , 1:1000, Novus Biologicals, NB100-122; Rabbit REST, 1:1000, Abcam, ab28018.
Chromatin immunoprecipitation. ChIP assays where performed as previously described60. Briefly, HEK293 
cells fully confluent on T175 flasks were conditioned to hypoxic media (1% oxygen) for the indicated time points. 
Cells were fixed with 2% formaldehyde in 10 mL fresh media for 10 min with agitation. Cells were removed from 
the hypoxic chamber and fixation was stopped with 125 mM glycine treatment for 5 min. The following mix was 
prepared: 1 uL of the purified DNA was used, 0.4 μ L of 20 μ M primers, 8 uL RNAse free water and 10 μ L of Power 
SYBR® Green (Applied Biosystems). The quantitative Real-Time PCR was performed using the 7900HT Fast 
Real-Time PCR System. Precipitated chromatin was normalized to input samples and the control IgG IP’s are 
shown as a negative control, as previously described60.
The following ChIP qRT-PCR primers were used:
HIF-RE1, F: AGAGGCTCGGAGCCGG, R: CGCTTCTCTCTAGTCTCACGAG
The following antibodies were used:
Rabbit CoREST, 5 μ g, Millipore, 07–455; Rabbit REST, 2 μ g, Millipore, 17–641; Rabbit mSin3A, 5 μ g, SCB, sc-994; 
Rabbit IgG, 5 μ g, Millipore, PP64B.
Glucose and lactate quantification assays. For the lactate assays (Trinity Biotechnology Lactate Assay 
Kit, REF735-10), 1 μ L of the supernatant or Lactate Standard Solution was incubated with 100 μ L of the Lactate 
Reagent Solution (lactate oxidase, peroxidase, chromogenic precursor and a pH 7.2 buffer), incubated at room tem-
perature for 10 min, absorbance at 540 nm was used to calculate the lactate concentration in the media, absorbance 
was corrected from blank. Lactate production relative to time zero was calculated and normalized to the protein 
concentration. For the glucose assays (Biovision, Glucose Assay Kit, REFK606-100) the media was diluted 1 in 10 
in Assay Buffer, 1.5 μ L of the diluted sample were mixed with 48 μ L of the Assay Buffer, 1 μ L of the Glucose Enzyme 
Mix and 1 μ L of the Glucose probe. This was followed by incubation for 30 min at 37 °C, protected from light, and 
absorbance was measured at 570 nm to calculate glucose concentration in the media relative to a standard curve 
of a supplied glucose standard, absorbance was corrected from blank. Glucose consumption relative to time zero 
was calculated and normalized to the protein concentration. For HEK293 cells treated with siRNA, transfection 
was performed as described under the “Gaussia Luciferase Assays” section.
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Bioinformatics identification of the RE1 elements. ChIP-Seq data obtained by the ENCODE con-
sortium across multiple cell lines and available at the UCSC genome browser (http://genome.ucsc.edu/) and 
the JASPAR database (http://jaspar.genereg.net/) of transcription factor binding sites, revealed the presence of a 
putative RE1 site on the HIF-1alpha promoter, located between 5207 and 5257 on the Homo sapiens HIF1A gene 
sequence on chromosome 14 (NCBI Reference Sequence: NG_029606.1). The Translation Start Site, referred to 
as ATG was determined by aligning the consensus coding sequence (CCDS) of HIF1A-001 (CCDS9753) to the 
HIF1A genomic DNA sequence. This corresponds to the uniprot entry (Q16665-1), the canonical HIF-1α isoform, 
with 826 amino acids (http://www.uniprot.org/uniprot/Q16665).
Statistical analysis. All experiments were performed at least 3 independent times. All immunoblots shown 
are representative of biological replicates. Data is shown as mean ± SEM. Statistical significance was tested in 
Prism (Graphpad), using Student’s t test for the comparison of two data sets or ANOVA for more than two datasets. 
*p < 0.05, **p < 0.01 and ***p < 0.001.
References
1. Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399–408, doi: 10.1016/j.cell.2012.01.021 (2012).
2. Elvidge, G. P. et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition-The 
role of HIF-1 alpha, HIF-2 alpha, and other pathways. J Biol Chem 281, doi: 10.1074/jbc.M511408200 (2006).
3. Manalo, D. J. et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659–669, 
doi: 10.1182/blood-2004-07-2958 (2005).
4. Benita, Y. et al. An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core 
response to hypoxia. Nucleic Acids Res 37, 4587–4602, doi: 10.1093/nar/gkp425 (2009).
5. Schofield, C. J. & Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5, 343–354, doi: 10.1038/nrm1366 (2004).
6. Prabhakar, N. R. & Semenza, G. L. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia 
mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 92, doi: 10.1152/physrev.00030.2011 (2012).
7. Howell, K., Preston, R. J. & McLoughlin, P. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary 
circulation. J Physiol 547, 133–145, doi: 10.1113/jphysiol.2002.030676 (2003).
8. Kato, Y. et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int 13, doi: 10.1186/1475-2867-13-89 (2013).
9. Colgan, S. P. & Taylor, C. T. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7, 281–287, 
doi: 10.1038/nrgastro.2010.39 (2010).
10. Metzen, E. et al. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-
responsive element. Biochem J 387, doi: 10.1042/bj20041736 (2005).
11. Cavadas, M. A. S., Nguyen, L. K. & Cheong, A. Hypoxia-inducible factor (HIF) network: insights from mathematical models. Cell 
Commun Signal 11, doi: 10.1186/1478-811X-11-42 (2013).
12. Bruning, U. et al. MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1 alpha Activity during Prolonged Hypoxia. Mol 
Cell Biol 31, doi: 10.1128/mcb.01276-10 (2011).
13. Uchida, T. et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression in 
lung epithelial cells-Implication of natural antisense HIF-1 alpha. J Biol Chem 279, 14871–14878, doi: 10.1074/jbc.M400461200 
(2004).
14. Chamboredon, S. et al. Hypoxia-inducible factor-1 alpha mRNA: a new target for destabilization by tristetraprolin in endothelial 
cells. Mol Biol Cell 22, 3366–3378, doi: 10.1091/mbc.E10-07-0617 (2011).
15. Thrash-Bingham, C. A. & Tartof, K. D. aHIF: A natural antisense transcript overexpressed in human renal cancer and during hypoxia. 
J Natl Cancer Inst 91, 143–151, doi: 10.1093/jnci/91.2.143 (1999).
16. Rossignol, F., Vache, C. & Clottes, E. Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal 
and tumour human tissues. Gene 299, 135–140, doi: 10.1016/s0378-1119(02)01049-1 (2002).
17. Ma, J., Zhang, L., Ru, G.-Q., Zhao, Z.-S. & Xu, W.-J. Upregulation of hypoxia inducible factor 1 alpha mRNA is associated with elevated 
vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World 
J Gastroenterol 13, 1680–1686 (2007).
18. Dai, C.-X. et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic 
factor in patients with HCC after surgery. BMC cancer 9, 418–418, doi: 10.1186/1471-2407-9-418 (2009).
19. Vainrib, M. et al. HIF1A C1772T polymorphism leads to HIF-1 alpha mRNA overexpression in prostate cancer patients. Cancer Biol 
Ther 13, 720–726, doi: 10.4161/cbt.20554 (2012).
20. Pipinikas, C. P., Carter, N. D., Corbishley, C. M. & Fenske, C. D. HIF-1 alpha mRNA gene expression levels in improved diagnosis of 
early stages of prostate cancer. Biomarkers 13, 680–691, doi: 10.1080/13547500802591992 (2008).
21. Wiener, C. M., Booth, G. & Semenza, G. L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res 
Commun 225, 485–488, doi: 10.1006/bbrc.1996.1199 (1996).
22. Yu, A. Y. et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol-Lung Cell 
Mol Physiol 275, L818–L826 (1998).
23. Chen, Y. R., Dai, A. G., Hu, R. C. & Jiang, Y. L. Differential and reciprocal regulation between hypoxia-inducible factor-alpha subunits 
and their prolyl hydroxylases in pulmonary arteries of rat with hypoxia-induced hypertension. Acta Biochim Biophys Sinica 38, 
423–434, doi: 10.1111/j.1745-7270.2006.00174.x (2006).
24. BelAiba, R. S. et al. Hypoxia up-regulates hypoxia-inducible factor-1 alpha transcription by involving phosphatidylinositol 3-kinase 
and nuclear factor kappa B in pulmonary artery smooth muscle cells. Mol Biol Cell 18, 4691–4697, doi: 10.1091/mbc.E07-04-0391 
(2007).
25. Palmer, L. A., Semenza, G. L., Stoler, M. H. & Johns, R. A. Hypoxia induces type II NOS gene expression in pulmonary artery 
endothelial cells via HIF-1. Am J Physiol-Lung Cell Mol Physiol 274, L212–L219 (1998).
26. Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated 
by cellular O2 tension. Proc Natl Acad Sci USA 92, 5510–5514, doi:10.1073/pnas.92.12.5510 (1995).
27. Jiang, B. H., Agani, F., Passaniti, A. & Semenza, G. L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription 
of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Res 57, 
5328–5335 (1997).
28. Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4, 891–899, doi: 10.1038/nrc1478 (2004).
29. Munoz-Pinedo, C., El Mjiyad, N. & Ricci, J. E. Cancer metabolism: current perspectives and future directions. Cell Death Dis 3, 
doi: 10.1038/cddis.2011.123 (2012).
30. Doe, M. R., Ascano, J. M., Kaur, M. & Cole, M. D. Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in 
Normal and Cancer Cells. Cancer Res 72, 949–957, doi: 10.1158/0008-5472.can-11-2371 (2012).
31. van Uden, P., Kenneth, N. S. & Rocha, S. Regulation of hypoxia-inducible factor-1 alpha by NF-kappa B. Biochem J 412, 477–484, 
doi: 10.1042/bj20080476 (2008).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:17851 | DOI: 10.1038/srep17851
32. Walczak-Drzewiecka, A., Ratajewski, M., Wagner, W. & Dastych, J. HIF-1 alpha is up-regulated in activated mast cells by a process 
that involves calcineurin and NFAT. J Immunol 181, 1665–1672 (2008).
33. Tadepally, H. D., Burger, G. & Aubry, M. Evolution of C2H2-zinc finger genes and subfamilies in mammals: Species-specific 
duplication and loss of clusters, genes and effector domains. BMC Evol Biol 8, doi: 10.1186/1471-2148-8-176 (2008).
34. Ooi, L. & Wood, I. C. Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8, doi: 10.1038/nrg2100 
(2007).
35. Negrini, S., Prada, I., D’Alessandro, R. & Meldolesi, J. REST: an oncogene or a tumor suppressor? Trends Cell Biol 23, 289–295, 
doi: 10.1016/j.tcb.2013.01.006 (2013).
36. Bruce, A. W. et al. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor 
(REST/NRSF) target genes. Proc Natl Acad Sci USA 101, 10458–10463, doi: 10.1073/pnas.0401827101 (2004).
37. Liu, Z., Liu, M., Niu, G., Cheng, Y. & Fei, J. Genome-wide identification of target genes repressed by the zinc finger transcription 
factor REST/NRSF in the HEK 293 cell line. Acta Biochim Biophys Sinica 41, 1008–1017, doi: 10.1093/abbs/gmp095 (2009).
38. Cheong, A. et al. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell 
proliferation. Mol Cell 20, 45–52, doi: 10.1016/j.molcel.2005.08.030 (2005).
39. Majumder, S. REST in good times and bad-Roles in tumor suppressor and oncogenic activities. Cell Cycle 5, doi: 10.4161/cc.5.17.2982 
(2006).
40. Mori, N., Schoenherr, C., Vandenbergh, D. J. & Anderson, D. J. A common silencer element in the SCG10 and type II Na + channel 
genes binds a factor present in nonneuronal cells but not in neuronal cells. Neuron 9, 45–54, doi: 10.1016/0896-6273(92)90219-4 
(1992).
41. Fitzpatrick, S. F. et al. An Intact Canonical NF-kappa B Pathway Is Required for Inflammatory Gene Expression in Response to 
Hypoxia. J Immunol 186, 1091–1096, doi: 10.4049/jimmunol.1002256 (2011).
42. Nguyen, L. K. et al. A dynamic model of the hypoxia-inducible factor 1α (HIF-1α ) network. J Cell Sci 126, 1454–1463, doi: 10.1242/
jcs.119974 (2013).
43. Barnes, P. J. & Larin, M. Mechanisms of disease-Nuclear factor-kappa b-A pivotal transcription factor in chronic inflammatory 
diseases. New Engl J Med 336, 1066–1071 (1997).
44. Greco, S. J., Smirnov, S. V., Murthy, R. G. & Rameshwar, P. Synergy between the RE-1 silencer of transcription and NF kappa B in the 
repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J Biol Chem 282, 30039–30050, doi: 10.1074/jbc.
M703026200 (2007).
45. Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, doi: 10.1038/
onc.2009.441 (2010).
46. Bao, B. et al. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs 
and tumor aggressiveness. BBA-Rev Cancer 1826, 272–296, doi: 10.1016/j.bbcan.2012.04.008 (2012).
47. Marin-Hernandez, A., Gallardo-Perez, J. C., Ralph, S. J., Rodriguez-Enriquez, S. & Moreno-Sanchez, R. HIF-1 alpha Modulates 
Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms. Mini Rev Med Chem 9, 1084–1101 
(2009).
48. Harris, A. L. Hypoxia-A key regulatory factor in tumour growth. Nat Rev Cancer 2, 38–47, doi: 10.1038/nrc704 (2002).
49. Semenza, G. L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8, S62–S67, doi: 10.1016/s1471-
4914(02)02317-1 (2002).
50. Furlan, D. et al. Up-regulation and stabilization of HIF-1 alpha in colorectal carcinomas. Surg Oncol 16, S25–S27, doi: 10.1016/j.
suronc.2007.10.014 (2007).
51. Westbrook, T. F. et al. SCF beta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. 
Nature 452, 370–U311, doi: 10.1038/nature06780 (2008).
52. Ganapathy-Kanniappan, S. & Geschwind, J.-F. H. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 
12, doi: 10.1186/1476-4598-12-152 (2013).
53. Ballas, N., Grunseich, C., Lu, D. D., Speh, J. C. & Mandel, G. REST and its corepressors mediate plasticity of neuronal gene chromatin 
throughout neurogenesis. Cell 121, 645–657, doi: 10.1016/j.cell.2005.03.013 (2005).
54. Walczak-Drzewiecka, A., Ratajewski, M., Pulaski, L. & Dastych, J. DNA methylation-dependent suppression of HIF1A in an immature 
hematopoietic cell line HMC-1. Biochem Biophys Res Commun 391, 1028–1032, doi: 10.1016/j.bbrc.2009.12.011 (2010).
55. Xu, J. et al. Epigenetic regulation of HIF-1 alpha in renal cancer cells involves HIF-1 alpha/2 alpha binding to a reverse hypoxia-
response element. Oncogene 31, 1065–1072, doi: 10.1038/onc.2011.305 (2012).
56. Narravula, S. & Colgan, S. P. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha 
expression during hypoxia. J Immunol 166, 7543–7548 (2001).
57. Lee, K. J., Lee, K. Y. & Lee, Y. M. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-
1 alpha to reverse HRE site in the promoter. BBA-Mol Cell Res 1803, 608–616, doi: 10.1016/j.bbamcr.2010.01.004 (2010).
58. Cavadas, M. A. S. & Cheong, A. Monitoring of Transcriptional Dynamics of HIF and NF kappa B Activities. Bioluminescent Imaging: 
Methods and Protocols 1098, 97–105, doi: 10.1007/978-1-62703-718-1_8 (2014).
59. Scholz, C. C. et al. Regulation of IL-1 beta-induced NF-kappa B by hydroxylases links key hypoxic and inflammatory signaling 
pathways. Proc Natl Acad Sci USA 110, 18490–18495, doi: 10.1073/pnas.1309718110 (2013).
60. Nguyen, L. K., Cavadas, M. A. S., Kholodenko, B. N., Frank, T. D. & Cheong, A. Species differential regulation of COX2 can be 
described by an NF kappa B-dependent logic AND gate. Cell Mol Life Sci 72, 2431–2443, doi: 10.1007/s00018-015-1850-1 (2015).
Acknowledgements
This work was supported by the Science Foundation Ireland under Grant No. 06/CE/B1129. We would like to thank 
Professor Louis B. Hersh (University of Kentucky, USA) for the kind gift of msREST-FLAG.
Author Contributions
M.A.S.C., C.T.T. and A.C. designed the study and experiments, M.A.S.C., M.M., B.C., M.C.M., A.C.S. and C.C.S. 
performed experiments, M.A.S.C., M.M., B.C., E.C., C.T.T. and A.C. analysed the data, M.A.S.C., C.T.T, S.B. and 
A.C. wrote the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Cavadas, M. A. S. et al. REST mediates resolution of HIF-dependent gene expression in 
prolonged hypoxia. Sci. Rep. 5, 17851; doi: 10.1038/srep17851 (2015).
www.nature.com/scientificreports/
1 2Scientific RepoRts | 5:17851 | DOI: 10.1038/srep17851
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
